×

UPSC Courses

DNA banner

DAILY NEWS ANALYSIS

GS-III :
  • 19 May, 2020

  • 3 Min Read

ChAdOx1 nCoV-19

ChAdOx1 nCoV-19

Context

A high-profile potential vaccine for COVID-19 being tested by researchers at Oxord University failed to protect vaccinated monkeys from being infected by the virus. However, the test animals appeared to be protected from pneumonia.

ChAdOx1 nCoV-19

  • The vaccine candidate, ChAdOx1 nCoV-19, being tested is a weakened form a common cold virus (adenovirus) that affects chimpanzees but has been neutered to prevent replication in humans.
  • Reports of the candidate vaccine’s performance in monkeys (rhesus macaque) have prompted researchers to test the vaccine’s potency in humans.
  • Its promise has also led to Indian vaccine manufacturer, the Pune-based Serum Institute announcing plans to manufacture a four to five million doses by end-May in India.

Source: TH


Students Achievement

Search By Date

Newsletter Subscription
SMS Alerts